Related Experiment Video
Updated: Feb 26, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Combinatorial interventions inhibit TGFβ-driven epithelial-to-mesenchymal transition and support hybrid cellular
Steven Nathaniel Steinway1, Jorge Gomez Tejeda Zañudo2, Paul J Michel3
1Penn State Hershey Cancer Institute, Penn State College of Medicine, Hershey, PA, USA.
Abstract:
Epithelial-to-mesenchymal transition (EMT) is a developmental process hijacked by cancer cells to leave the primary tumor site, invade surrounding tissue and establish distant metastases. A hallmark of EMT is the loss of E-cadherin expression, and one major signal for the induction of EMT is transforming growth factor beta (TGFβ), which is dysregulated in up to 40% of hepatocellular carcinoma (HCC). We aim to identify network perturbations that suppress TGFβ-driven EMT, with the goal of suppressing invasive properties of cancer cells. We use a systems-level Boolean dynamic model of EMT to systematically screen individual and combination perturbations (inhibition or constitutive activation of up to four nodes). We use a recently developed network control approach to understand the mechanism through which the combinatorial interventions suppress EMT. We test the results of our in silico analysis using siRNA. Our model predicts that targeting key elements of feedback loops in combination with the SMAD complex is more effective than suppressing the SMAD complex alone. We demonstrate experimentally that expression of a majority of these elements is enriched in mesenchymal relative to epithelial phenotype HCC cell lines. An siRNA screen of the predicted combinations confirms that many targeting strategies suppress TGFβ-driven EMT measured by E-cadherin expression and cell migration. Our analysis reveals that some perturbations give rise to hybrid states intermediate to the epithelial and mesenchymal states. Our results indicate that EMT is driven by an interconnected signaling network and many apparently successful single interventions may lead to steady states that are in-between epithelial and mesenchymal states. As these putative hybrid or partial EMT states may retain invasive properties, our results suggest that combinatorial therapies are necessary to fully suppress invasive properties of tumor cells.
Insights
Combinatorial therapies targeting key feedback loops and SMAD complexes effectively suppress transforming growth factor beta (TGFβ)-driven epithelial-to-mesenchymal transition (EMT) in hepatocellular carcinoma (HCC). This approach is crucial for fully inhibiting cancer cell invasion and metastasis.
Area of Science:
- Cancer Biology
- Systems Biology
- Molecular Oncology
Background:
- Epithelial-to-mesenchymal transition (EMT) drives cancer cell invasion and metastasis, a process often hijacked from development.
- Transforming growth factor beta (TGFβ) signaling is a key inducer of EMT and is frequently dysregulated in hepatocellular carcinoma (HCC).
- Loss of E-cadherin expression is a hallmark of EMT, correlating with increased cancer cell invasiveness.
Purpose of the Study:
- To identify network perturbations that can suppress TGFβ-driven EMT in cancer cells.
- To understand the mechanisms by which combinatorial interventions inhibit cancer cell invasion.
- To validate computational predictions through experimental testing.
Main Methods:
- Development and application of a systems-level Boolean dynamic model of EMT.
- Systematic screening of individual and combination perturbations using a network control approach.
- Experimental validation using siRNA in HCC cell lines and assessment of E-cadherin expression and cell migration.
Main Results:
- Computational models predicted that combined targeting of feedback loops and SMAD complexes is more effective than targeting SMAD alone.
- Experimental validation confirmed that many predicted combinatorial targeting strategies significantly suppress TGFβ-driven EMT.
- Observed that some interventions result in hybrid epithelial-mesenchymal states, which may retain invasive properties.
Conclusions:
- EMT is driven by an interconnected signaling network, necessitating combinatorial therapies for complete suppression of invasive properties.
- Single interventions may lead to intermediate or partial EMT states, underscoring the need for multi-target strategies.
- Combined targeting approaches are essential to fully inhibit the invasive potential of tumor cells by overcoming resistance mechanisms.
More Related Videos
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
07:05TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
Related Concept Videos
TGF - β Signaling Pathway
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Forced Transdifferentiation
Artificial...